Therapeutic Areas: Dermatology | Oncology | Family Medicine

Melanoma Clinical Trials

A listing of Melanoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Incyte Corporation
Birmingham Alabama

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

UPDATED

Muscle Shoals Alabama 35661

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Birmingham Alabama 35243

A clinical research study of TLPLDC Vaccine for the treatment of Metastatic Melanoma

Birmingham Alabama 35243

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Immediate surgical resection of melanoma lesion(s) for the treatment of Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma

Birmingham Alabama

Patients are needed to participate in a clinical research study of Nivolumab + INCB24360

Mobile Alabama 36608

A clinical research study of talimogene laherparepvec, pembrolizumab (MK-3475) and placebo for the treatment of Melanoma, Unresected Melanoma

Mobile Alabama 36608

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Muscle Shoals Alabama 35661

Patients are needed to participate in a clinical research study to evaluate Melanoma

Arizona

Incyte Corporation
Scottsdale Arizona

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

UPDATED

Gilbert Arizona 85234

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine

UPDATED

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Scottsdale Arizona 85259

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Chandler Arizona 85224

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Dabrafenib 150 mg twice a day (BID), Rabeprazole 40 mg once daily (OD) and Rifampin 600 mg OD for patients with Cancer

Goodyear Arizona

Patients are needed to participate in a clinical research study of TSR-022 and anti PD-1 antibody to evaluate Advanced or Metastatic Solid Tumors

Phoenix Arizona 85054

A clinical trial to evaluate treatments using HBI-8000 in combination with nivolumab for patients with Melanoma, Renal Cell Carcinoma or Non-Small Cell Lung Cancer

Phoenix Arizona 85054

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Phoenix Arizona 85054

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Phoenix Arizona 85018

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Phoenix Arizona 85032

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Scottsdale Arizona

A clinical trial to evaluate treatments using DCC-2618 for patients with Gastrointestinal Stromal Tumors, Aggressive Systemic Mastocytosis or Advanced Cancers

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating PLX3397 and Pembrolizumab to treat Advance Melanoma and Other Solid Tumors

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Tucson Arizona 85719

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Arkansas

Incyte Corporation
Little Rock Arkansas

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

Fayetteville Arkansas 72703

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Fayetteville Arkansas 72703

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Hot Springs Arkansas 71913

Patients are needed to participate in a clinical research study to evaluate Melanoma

Hot Springs Arkansas 71913

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Little Rock Arkansas 72205

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

California

Incyte Corporation
Los Angeles California

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

Incyte Corporation
San Francisco California

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

Incyte Corporation
Santa Barbara California

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

Incyte Corporation
Santa Monica California

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

Incyte Corporation
Santa Monica California

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating Ipilimumab and Nivolumab for the treatment of Melanoma

UPDATED

La Jolla California 92093

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

La Jolla California 92037

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

La Jolla California 92037

A Phase 4 clinical study for patients using Pasireotide

UPDATED

Los Angeles California 90048

A clinical trial seeking patients for a research study for the treatment of Malignant Neoplasms

UPDATED

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Malignant Neoplasms

UPDATED

Los Angeles California 90027

A clinical trial seeking patients for a research study for the treatment of Melanoma, Lymphoma or Solid Tumor

UPDATED

Los Angeles California 90048

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

UPDATED

Los Angeles California 90032

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Los Angeles California 90048

A Phase 4 clinical study for patients using Pasireotide